Qin Li

Qin Li is a Principal Scientist currently at Legend Biotech since October 2025, with previous experience as Principal Scientist in Translational Pharmacology at Shoreline Biosciences, Inc. from December 2021 to April 2025. Prior roles include Associate Director and Senior Scientist in Oncology at BioDuro between March 2020 and December 2021, and a Postdoctoral Scholar at UC San Diego Health from February 2014 to March 2020, where Qin Li focused on screening glioblastomas resistant to anti-angiogenesis treatment using in vivo models. Educational qualifications include a Ph.D. in Genetics from UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, a Master of Science in Biochemistry from the University of Saskatchewan, and a Bachelor of Science in Biotechnology from Beijing Normal University.